Clinical Trial Update: To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM [NA]

View source ↗

Summary

A recruiting clinical trial evaluating Ezefeno tablets in patients with type 2 diabetes mellitus and dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ezefeno Tab.

Snippet

Sponsor: Korea University Anam Hospital | Conditions: T2DM (Type 2 Diabetes Mellitus), Dyslipidemias | NA | Status: RECRUITING